Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker KALA
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | SCHEDULE 13G | KALA KALA BIO, Inc. | Labkowski Nachum | 966,991 | 5.0% | SCHEDULE 13G ↗ |
| Jul 2, 2026 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | David E. Lazar | 719,404 | 3.9% | SCHEDULE 13D/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Felix J. Baker | 2,312 | 0.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Julian C. Baker | 2,312 | 0.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Baker Bros. Advisors (GP) LLC | 2,312 | 0.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Baker Bros. Advisors LP | 2,312 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Felix J. Baker | 2.89M | 10.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Julian C. Baker | 2.89M | 10.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Baker Bros. Advisors (GP) LLC | 2.89M | 10.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Baker Bros. Advisors LP | 2.89M | 10.0% | SCHEDULE 13G/A ↗ |
| Feb 6, 2026 | SCHEDULE 13D | KALA KALA BIO, Inc. | David E. Lazar | 49.50M | 5.2% | SCHEDULE 13D ↗ |
| Jan 13, 2026 | SCHEDULE 13G | KALA KALA BIO, Inc. | Michael Rice | 2.20M | 7.9% | SCHEDULE 13G ↗ |
| Jan 13, 2026 | SCHEDULE 13G | KALA KALA BIO, Inc. | Andrew McDonald | 2.20M | 7.9% | SCHEDULE 13G ↗ |
| Jan 13, 2026 | SCHEDULE 13G | KALA KALA BIO, Inc. | LifeSci Capital LLC | 2.20M | 7.9% | SCHEDULE 13G ↗ |
| Dec 3, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Oxford Finance LLC | 1.62M | 16.5% | SCHEDULE 13G ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Perceptive Life Sciences Master Fund, Ltd. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Joseph Edelman | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Perceptive Advisors LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Bihua Chen | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Cormorant Asset Management, LP | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Steven A. Cohen | 257 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Point72 Capital Advisors, Inc. | 257 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Point72 Asset Management, L.P. | 257 | 0.0% | SCHEDULE 13G/A ↗ |
| Oct 15, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | George Simeon | 344,176 | 4.6% | SCHEDULE 13D/A ↗ |
| Oct 15, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | SR One Capital Management, LLC | 344,176 | 4.6% | SCHEDULE 13D/A ↗ |
| Oct 15, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | SR One Capital Partners II, LP | 344,176 | 4.6% | SCHEDULE 13D/A ↗ |
| Oct 15, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | SR One Capital Fund II Aggregator, LP | 344,176 | 4.6% | SCHEDULE 13D/A ↗ |
| Oct 3, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Felix J. Baker | 744,759 | 10.0% | SCHEDULE 13G ↗ |
| Oct 3, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Julian C. Baker | 744,759 | 10.0% | SCHEDULE 13G ↗ |
| Oct 3, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Baker Bros. Advisors (GP) LLC | 744,759 | 10.0% | SCHEDULE 13G ↗ |
| Oct 3, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Baker Bros. Advisors LP | 744,759 | 10.0% | SCHEDULE 13G ↗ |
| Oct 2, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | Felix J. Baker | 744,759 | 10.0% | SCHEDULE 13D/A ↗ |
| Oct 2, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | Julian C. Baker | 744,759 | 10.0% | SCHEDULE 13D/A ↗ |
| Oct 2, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | Baker Bros. Advisors (GP) LLC | 744,759 | 10.0% | SCHEDULE 13D/A ↗ |
| Oct 2, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | Baker Bros. Advisors LP | 744,759 | 10.0% | SCHEDULE 13D/A ↗ |
| Oct 1, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | George Simeon | 411,000 | 5.5% | SCHEDULE 13D/A ↗ |
| Oct 1, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | SR One Capital Management, LLC | — | 5.5% | SCHEDULE 13D/A ↗ |
| Oct 1, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | SR One Capital Partners II, LP | 411,000 | 5.5% | SCHEDULE 13D/A ↗ |
| Oct 1, 2025 | SCHEDULE 13D/A (amended) | KALA KALA BIO, Inc. | SR One Capital Fund II Aggregator, LP | 411,000 | 5.5% | SCHEDULE 13D/A ↗ |
| Sep 11, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Perceptive Life Sciences Master Fund, Ltd. | 543,745 | 7.7% | SCHEDULE 13G ↗ |
| Sep 11, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Joseph Edelman | 543,745 | 7.7% | SCHEDULE 13G ↗ |
| Sep 11, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Perceptive Advisors LLC | 543,745 | 7.7% | SCHEDULE 13G ↗ |
| Sep 11, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Steven A. Cohen | 469,229 | 6.7% | SCHEDULE 13G ↗ |
| Sep 11, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Point72 Capital Advisors, Inc. | 469,229 | 6.7% | SCHEDULE 13G ↗ |
| Sep 11, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Point72 Asset Management, L.P. | 469,229 | 6.7% | SCHEDULE 13G ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Israel A. Englander | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Millennium Group Management LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | KALA KALA BIO, Inc. | Millennium Management LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Bihua Chen | 609,027 | 10.0% | SCHEDULE 13G ↗ |
| Feb 14, 2025 | SCHEDULE 13G | KALA KALA BIO, Inc. | Cormorant Asset Management, LP | 609,027 | 10.0% | SCHEDULE 13G ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances